Why the study?
This review aimed to evaluate the effectiveness of psychotherapeutic, psychopharmacological, and psychosocial interventions in the prevention and treatment of cardiovascular disease.
Do psychocorrective interventions improve psychological and cardiometabolic outcomes in patients with or at risk for cardiovascular disease?
Do psychocorrective interventions improve psychological and cardiometabolic outcomes in patients with or at risk for cardiovascular disease?
The integration of psychosocial and psychopharmacological interventions into treatment approaches is a promising area for primary and secondary cardiovascular prevention.
Answers are grounded in this paper and cite their sources.
Psychocorrective interventions benefit CVD patients; reinforces RCT evidence and supports multiprofessional prevention strategies.
Objective . Literature review aimed to study the effectiveness of psychotherapeutic, psychopharmacological and psychosocial interventions in the prevention and treatment of cardiovascular disease (CVD). Design and methods . The search of scientific and medical publications was updated using the English language electronic search system PubMed and the domestic platform elibrary.ru with a focus on systematic reviews, metaanalyses, and randomized controlled trials. Results . An overwhelming number of papers report positive effects of psychocorrective interventions on regression of psychological syndromes, stress, as well as on cardiometabolic parameters (including hyperlipidemia, cardiovascular remodeling) and CVD/events. In addition, we analyzed foreign and domestic experience in organizing psychological and psychotherapeutic care for patients, based on integrative and multidisciplinary approach. Conclusions . The available evidence supports the effectiveness of some psychocorrective interventions in patients with CVD. The integration of psychosocial and psychopharmacological interventions into treatment approaches (multiprofessional approach) is a promising area of primary and secondary cardiovascular prevention.
No takes yet. Share an insight, caveat, or question.
Bastrikov et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: